Construction and Evaluation of a Flipped Discharge Model for Stomates With Colorectal Cancer
Construction and Empirical Study of a "Flipped" Discharge Model for Colorectal Cancer Patients With Stoma Based on Response Transformation Theory Research
2 other identifiers
interventional
200
1 country
1
Brief Summary
This multicenter randomized controlled trial aims to develop and evaluate the effectiveness of a "Flipped Discharge" intervention for colorectal cancer patients with a new intestinal stoma. Guided by the Response to Transition Theory, the model addresses the care gap during the vulnerable post-discharge period by shifting critical support from the hospital to the patient's home. Approximately 200 eligible patients will be randomized into either the intervention or standard care control group. The core "Flipped Discharge" intervention occurs on the third day post-discharge, delivered either as an in-home visit by a specialist stoma nurse (via an "Internet + Nursing Service" platform) or as an intensive, standardized video follow-up with mailed instructional materials. The study's primary outcome is the incidence of stoma-related complications. Secondary outcomes include quality of life, self-care ability, self-efficacy, stoma adaptation, discharge readiness, healthcare costs, and satisfaction. The trial will also explore the mechanisms by which the intervention affects patient outcomes, ultimately seeking to provide evidence for a feasible, patient-centered model to improve care continuity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable colorectal-cancer
Started Mar 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 29, 2025
CompletedStudy Start
First participant enrolled
March 10, 2026
CompletedFirst Posted
Study publicly available on registry
March 11, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2027
March 11, 2026
December 1, 2025
1.8 years
December 29, 2025
March 5, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of stoma and peristomal skin complications
The occurrence of complications related to the intestinal stoma and the surrounding skin will be assessed using a standardized Stoma Complication Assessment Form. This form evaluates six major items: changes in peristomal skin, degree of stoma prolapse, presence of parastomal hernia, degree of stoma stenosis, degree of stoma retraction, and degree of stoma mucocutaneous separation. Each item has specific criteria and a scoring system, with a higher total score indicating a greater number and severity of complications.
From the initiation of the intervention (post-discharge) up to 1 month postoperatively, or as defined by the primary study endpoint period.
Secondary Outcomes (10)
Level of adaptation to the stoma
From the initiation of the intervention (post-discharge) up to 1 month postoperatively, or as defined by the primary study endpoint period.
Level of stoma-related self-efficacy
From the initiation of the intervention (post-discharge) up to 1 month postoperatively, or as defined by the primary study endpoint period.
Readiness for hospital discharge
Assessed at the core intervention point (approximately 3 days post-discharge).
Disease-specific quality of life
From the initiation of the intervention (post-discharge) up to 1 month postoperatively, or as defined by the primary study endpoint period.
Self-care ability for stoma management
From the initiation of the intervention (post-discharge) up to 1 month postoperatively, or as defined by the primary study endpoint period.
- +5 more secondary outcomes
Study Arms (2)
Flipped Discharge Model Group
EXPERIMENTALParticipants receive the "Flipped Discharge" intervention based on Response to Transition Theory. This includes standardized post-discharge telephone follow-ups on days 1-2. The core intervention occurs around day 3 (±1 day), delivered either via an in-home visit by a certified stoma nurse through the hospital's "Internet + Nursing Service" platform or, for eligible patients outside the service area, a standardized intensive video follow-up (≥30 min) with a mailed stoma care kit. Additional telephone support is provided at 1 week. All interventions follow a central protocol and are conducted by trained, certified stoma care specialists.
Standard Care Group
NO INTERVENTIONParticipants receive routine post-discharge care and follow-up as per the current standard practice at their respective hospital centers. This typically includes conventional discharge education and scheduled follow-up contacts (e.g., phone calls) conducted by hospital staff according to local protocols, without the structured, early in-home or intensive video intervention provided to the intervention group.
Interventions
This is a structured, multi-component continuing care intervention initiated after hospital discharge for colorectal cancer patients with an intestinal stoma. Based on the Response to Transition Theory, it aims to support patients' adaptation during the critical early post-discharge period. The core intervention is a standardized assessment and education session conducted around the third day post-discharge. This is delivered flexibly based on patient location: either an in-home visit by a certified enterostomal therapist via a hospital-approved "Internet + Nursing Service" platform, or a standardized, intensive video follow-up (≥30 minutes) coupled with a mailed stoma care kit for those outside the service area. The intervention is complemented by protocol-driven telephone follow-ups on days 1-2 and at 1 week to reinforce education, provide psychological support, and address individual concerns.
Eligibility Criteria
You may qualify if:
- Pathologically diagnosed colorectal cancer patients undergoing their first radical surgery with either abdominoperineal resection (Miles) plus permanent colostomy or sphincter-preserving anterior resection (Dixon) plus temporary ileostomy.
- Aged 18 years or older.
- Possess at least elementary school education and are able to read, communicate, and understand questionnaire content. Voluntarily participate and provide written informed consent.
- Postoperative condition is stable without major complications, and patient is conscious.
- Meets standard hospital discharge criteria with normally functioning stoma.
You may not qualify if:
- History of psychiatric disorders or severe cognitive impairment.
- Diagnosis with other concurrent malignancies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate chief nurse
Study Record Dates
First Submitted
December 29, 2025
First Posted
March 11, 2026
Study Start
March 10, 2026
Primary Completion (Estimated)
December 30, 2027
Study Completion (Estimated)
December 30, 2027
Last Updated
March 11, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share